These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10927839)

  • 1. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():19-20. PubMed ID: 10927839
    [No Abstract]   [Full Text] [Related]  

  • 2. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 3. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B.
    Can Commun Dis Rep; 1992 Aug; 18(16):121-2. PubMed ID: 1290997
    [No Abstract]   [Full Text] [Related]  

  • 5. Statement on hepatitis B vaccine. National Advisory Committee on Immunization.
    CMAJ; 1993 Nov; 149(10):1465-80. PubMed ID: 8221430
    [No Abstract]   [Full Text] [Related]  

  • 6. Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():12-8. PubMed ID: 10927838
    [No Abstract]   [Full Text] [Related]  

  • 7. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 8. National Advisory Committee on Immunization (NACI) statement on universal immunization against hepatitis B.
    Carter AO; Walsh P
    Can Dis Wkly Rep; 1991 Aug; 17(31):165-71. PubMed ID: 1913935
    [No Abstract]   [Full Text] [Related]  

  • 9. Statement on the recommended use of pentavalent and hexavalent vaccines. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Feb; 33(ACS-1):1-14. PubMed ID: 17294559
    [No Abstract]   [Full Text] [Related]  

  • 10. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
    Tam T; Langley J;
    Can Commun Dis Rep; 2004 Mar; 30():1-5. PubMed ID: 15035403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statement on immunization for Lyme disease (ACS-3). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():1-11. PubMed ID: 10927837
    [No Abstract]   [Full Text] [Related]  

  • 12. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on smallpox vaccination.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-1):1-12. PubMed ID: 12728646
    [No Abstract]   [Full Text] [Related]  

  • 13. School-based adolescent hepatitis B vaccination.
    Cassidy WM
    J La State Med Soc; 1999 Dec; 151(12):622-6. PubMed ID: 10643204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on recommended use of pneumococcal conjugate vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Jan; 28(ACS-2):1-32. PubMed ID: 12728645
    [No Abstract]   [Full Text] [Related]  

  • 15. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2003 Aug; 29():1-20. PubMed ID: 12961958
    [No Abstract]   [Full Text] [Related]  

  • 16. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season.
    Can Commun Dis Rep; 1998 Jul; 24():1-12. PubMed ID: 10330776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2001 Jan; 27():1-3. PubMed ID: 11227823
    [No Abstract]   [Full Text] [Related]  

  • 18. Guidelines for Childhood Immunization Practices. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 1997 Dec; 23():1-12. PubMed ID: 9447783
    [No Abstract]   [Full Text] [Related]  

  • 19. Statement on influenza vaccination for the 2000-2001 season. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jun; 26():1-16. PubMed ID: 10920540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine.
    De Serres G
    Can Commun Dis Rep; 2000 May; 26():1-8. PubMed ID: 10893823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.